China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD)
China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. Its contractually controlled affiliates include Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine General Partnership, and Hangzhou Jiuzhou Medical & Public Health Service Co., Ltd. The chain has stores throughout Hangzhou, the provincial capital of Zhejiang Province.
China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD)’s Financial Overview
China Jo-Jo Drugstores, Inc. (NASDAQ) surged 2.74% yesterday to close its trading session at $2.25. The company has 1 year Price Target of $7. China Jo-Jo Drugstores, Inc. has 52-Week high of $2.46 and 52-Week Low of $1.17. The stock touched its 52-Week High on 2.46 and 52-Week Low on 1.17. The stock traded with the volume of 244748 shares yesterday. The firm shows the market capitalization of $63.41 Million.
The firm is trading with SMA20 of 5.22 Percent, SMA50 of 4.56 Percent and SMA200 of 32.8 percent. China Jo-Jo Drugstores, Inc. has P/S value of 0.63 while its P/B value stands at 4.09. Similarly, the company has Return on Assets of -24.1 percent, Return on Equity of -84.9 percent and Return on Investment of -47.5 Percent. The company shows Gross Margin and Operating Margin of 21.6 percent and -17 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 1 analysts offering 12-month price forecasts for China Jo-Jo Drugstores Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +211.10% increase from the last price of 2.25.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Vulcan Materials Company (NYSE:VMC)
Vulcan Materials Company, a member of the S&P 500 Index, is the nation’s largest producer of construction aggregates, a major producer of asphalt mix and concrete, and a leading producer of cement in Florida.
Vulcan Materials Company (NYSE:VMC)’s Financial Outlook
The 16 analysts offering 12-month price forecasts for Vulcan Materials Co have a median target of 125.00, with a high estimate of 140.00 and a low estimate of 103.00. The median estimate represents a +20.81% increase from the last price of 103.47.
Vulcan Materials Company is expected* to report earnings on 02/14/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.87. The reported EPS for the same quarter last year was $0.74.
According to Zacks Investment Research, Vulcan Materials Company has a Consensus Recommendation of 1.6. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 1.58% and closed its last trading session at $103.47. The company has the market capitalization of $13.7 Billion. The stock has 52-week high of $134.44 and 52-Week low of $82.52. The firm touched its 52-Week high on 134.44 and 52-Week low on 82.52. The company has volume of 1.23 Million shares. The company has a total of 132.39 Million shares outstanding.
Vulcan Materials Company (NYSE) in the last quarter reported its actual EPS of $1.4/share where the analyst estimated EPS was $1.38/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 1.4 percent.
The company has YTD performance of 4.73 percent. Beta for Vulcan Materials Company stands at 0.89 while its ATR (average true range) is 2.77. The company has Weekly Volatility of 2.38%% and Monthly Volatility of 2.56%%.
Vulcan Materials Company has distance from 20-day Simple Moving Average (SMA20) of 1.52%, Distance from 50-Day Simple Moving Average of 2.43 percent and Distance from 200-Day Simple Moving Average of -7.59%.
The Company currently has ROA (Return on Assets) of 4.6 percent, Return on Equity (ROE) of 8.9 Percent and Return on Investment (ROI) of 7.4% with Gross margin of 25 percent and Operating & Profit margin of 15% and 10.4% respectively.